2 points | by randycupertino 5 hours ago ago
3 comments
Novo's stock jumped 8% on this news, and HIMS pulled their compounded weightloss pill in the face of mounting legal and regulatory pressure.
Feel like the next shoe to drop will be supply chain- going after API suppliers and the compounders.
Their international patents expire this year, so it'll become a game of whack-a-mole trying to stop individuals from importing generics.
No surprise
Novo's stock jumped 8% on this news, and HIMS pulled their compounded weightloss pill in the face of mounting legal and regulatory pressure.
Feel like the next shoe to drop will be supply chain- going after API suppliers and the compounders.
Their international patents expire this year, so it'll become a game of whack-a-mole trying to stop individuals from importing generics.
No surprise